Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2007-07-30
2010-11-16
Minnifield, N. M (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S269100, C424S184100, C424S093100
Reexamination Certificate
active
07833537
ABSTRACT:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.
REFERENCES:
patent: 6764838 (2004-07-01), Weinstock et al.
patent: 7250173 (2007-07-01), Weinstock et al.
patent: 2003/0039666 (2003-02-01), Weinstock et al.
patent: 2004/0202671 (2004-10-01), Weinstock et al.
patent: 2005/0118655 (2005-06-01), Weinstock et al.
patent: 2007/0298011 (2007-12-01), Weinstock et al.
patent: 2009/0074818 (2009-03-01), Kapel et al.
patent: 2010/0124574 (2010-05-01), Kapel et al.
Sartor, Gastroenterology Clinics of North America, 1995, 24/3:475-507.
Moreels et al, Inflammatory Bowel Disease, 2009, 51/4:491-500 abstract only.
Bazzone et al, Infection and Immunity, 2008, 76/11:5164-5172.
Setiawan et al, Infection and Immunity, 2007, 75/9:4655-4663.
Braezzer, Acta Paediatr Suppl., 1994, 395:18-21.
Metwali et al, Gastroenterology, Apr. 2008, 134/4(Suppl. 1):A261 abstract only.
Summers et al, Gastroenterology, 2004, 126/4(Suppl. 2):A75 abstract only.
Elliott et al. In: Hygiene Hypothesis and Darwinian Medicine, 2009, Rook (ed.), pp. 149-178.
Elliott et al, Current Opinion Gastroenterology, 2005, 21/1:51-58 abstract only.
Rook, Immunology, 2008, 126:3-11.
Erb, Trends in Immunology, 2008, 30/2:75-82.
Weinstock et al, J. Lab. Clin. Med., 2002, 139:334-338.
Tanaka, Japanese Journal Parasitology, 1981, 30/4:345-354 abstract only.
Weinstock et al, Gut, 2004, 53:7-9.
Weinstock et al, Inflammatory Bowel Disease, Jan. 2009, 15/1:128-133.
Weinstock et al, Springer Semin. Immunol., 2005, 27:249-271.
Elliott et al International J Parasitology, 2007, 37:457-464.
Braus et al, Clinical Immunology, 2009, 132:1-9.
Summers et al, American Journal Gastroenterology, 2003, 98/9:2034-2041.
Elliott David E.
Weinstock Joel V.
DeCloux Amy
Edwards Angell Palmer & & Dodge LLP
Minnifield N. M
University of Iowa Research Foundation
Williams Kathleen
LandOfFree
Use of parasitic biological agents for prevention and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of parasitic biological agents for prevention and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of parasitic biological agents for prevention and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4193366